Polycystic kidney disease
An inherited condition in which many small sacs of fluid (cysts) grow in the kidneys and slowly stop them working well. Signs often start between 30 and 40: tummy pain, high blood pressure, blood in the pee or kidney stones. There is no cure, but a medicine called tolvaptan can slow cyst growth in some adults. A child of an affected parent has a 1 in 2 chance of getting it.
Read more about polycystic kidney diseaseTrial-stage treatments and research studies you can join
Filters
- Tests tolvaptan in infants and children with polycystic kidney disease
Tests tolvaptan for safety in young children with autosomal recessive polycystic kidney disease.
Warsaw, PolandAge 0 to 18
Where treatment stands
There is no cure yet, but some medicine can slow the growth of cysts and help the kidneys work for longer, and related problems can be treated.
Approved: 1
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 3
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 4
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 3
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.
Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 8 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for polycystic kidney disease. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in Poland, for you and your family.
We have no organisations for this disease listed in Poland yet. General support there is below.
General support in Poland
- Centrum Wsparcia dla osób dorosłych w kryzysie psychicznym
Free 24/7 support line (800 70 2222) and chat for adults in psychological crisis in Poland, funded by the Ministry of Health.
- pacjent.gov.pl
Patient portal of the Polish Ministry of Health and National Health Fund with reliable, verified information on health and the care system.
- Rzecznik Praw Pacjenta
Poland's central government Patient Ombudsman protecting patient rights, with a free patient helpline (800 190 590).
International organisations
Offer tissue or data
There are three ways to help research move faster.
Approved treatments
1 medicine is approved for polycystic kidney disease in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.
Checked on 11 Nov 2026 in the official lists of the US (FDA), the EU (EMA), Japan (PMDA, approvals since April 2004), Switzerland (Swissmedic), France (ANSM, medicines approved in France only) and Taiwan (TFDA). For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. Other countries' own approvals were not checked.
“Miracle cure” fact checker
Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- CBD (cannabidiol) & Polycystic kidney disease
- Omega-3 fatty acids (fish oil) & Polycystic kidney disease
- Curcumin (turmeric) & Polycystic kidney disease
- Stem cell treatment & Polycystic kidney disease
About polycystic kidney disease
Source: NHS
An inherited condition in which many small sacs of fluid (cysts) grow in the kidneys and slowly stop them working well. Signs often start between 30 and 40: tummy pain, high blood pressure, blood in the pee or kidney stones. There is no cure, but a medicine called tolvaptan can slow cyst growth in some adults. A child of an affected parent has a 1 in 2 chance of getting it.
What is it?
In polycystic kidney disease, many small sacs filled with fluid (cysts) form in the kidneys. A fault in a gene, most often PKD1 or PKD2, upsets how kidney cells grow. You are born with it, but it usually causes no problems until the cysts are big enough to affect the kidneys, most often between 30 and 40.
It is the most common inherited kidney condition, though still relatively uncommon: it is estimated that up to 1 in every 1,000 to 2,500 people in the UK has it. If one parent has the faulty gene, each child has a 1 in 2 chance of getting it. In about 1 in 10 people the gene fault is new, and they can pass it on. A rarer form, autosomal recessive PKD, needs a faulty gene from both parents and usually starts in childhood.
The first signs
When signs appear, they can include:
- pain in the tummy;
- high blood pressure;
- blood in the pee, which you may not be able to see;
- upper urinary tract infections, which can be serious;
- kidney stones.
How doctors find out
Your family doctor asks about your symptoms and family, checks your blood pressure and urine, and does a blood test to see how well your kidneys filter. A painless ultrasound scan looks for cysts in the kidneys and other organs such as the liver; sometimes a CT or MRI scan is needed. Genetic blood tests are used only in special cases. Very small cysts can be missed in young people, so a scan may need repeating later. Testing children or relatives without signs has pros and cons. If brain aneurysms run in your family, an MRI scan of the brain is recommended.
Current treatment
Blood pressure medicines (ACE inhibitors or ARBs) and less salt; tolvaptan to slow cyst growth in some adults whose kidney disease is getting worse quickly; dialysis or a transplant if the kidneys fail.
Will it get worse?
It differs a lot between people. Kidney function may slowly get worse over time. Some people reach kidney failure soon after finding out, while others keep fairly good kidneys all their life; on average about half of people need treatment for kidney failure by age 60. High blood pressure raises the risk of heart attack and stroke, and a bulging blood vessel in the brain (aneurysm) can bleed.
Medicines: what helps, and what to watch for
High blood pressure is usually treated with medicines, most often ACE inhibitors or ARBs. Tolvaptan is a tablet taken twice a day that slows cyst growth and helps keep the kidneys working for longer; it can only be used in adults who have chronic kidney disease (stage 2 or 3) at the start of treatment and signs that the kidney disease is getting worse quickly. Antibiotics treat urine infections, though infections in the cysts are harder to cure, and painkillers can ease the pain.
Good to know:
- paracetamol is the first choice for pain; painkillers such as ibuprofen (NSAIDs) are usually avoided, because they can harm the kidneys and work against blood pressure medicines;
- tolvaptan often makes you thirsty and need to pee more, also at night;
- tolvaptan has caused liver damage in some people, so at first you are monitored often through hospital clinics;
Dialysis or a transplant, for some people
Large kidney stones can be broken up with shock waves or removed with a thin tube, and large cysts can sometimes be drained. When the kidneys fail, dialysis (a machine does some of their work) or a kidney transplant are the main options. You only need one kidney to survive, so a living person can donate a kidney; close relatives usually make the best match. Some people choose care focused on comfort instead.
Is there a cure?
No, there is currently no cure. The cysts cannot be prevented, but treatment can slow their growth and manage the problems they cause.
Sources
Written in plain words by Frontlight from these pages: